The degradation of β-catenin is mediated by the phosphokinase activity of GSK-3β [27–29], which is inhibited through phosphorylation by activated phospho-AKT, another classic oncogenic kinase playing a remarkable role in tumor progression [30–33]. This evidence concerns the gene GSK3B and neoplasm.